How we Investigate Bone Marrow Failure Syndromes in Pediatric Patients

Area of Science:

• Hematology
• Pediatric Oncology
• Genetics

Background:

• Bone marrow failure syndromes (BMFS) are complex hematologic disorders.
• Distinguishing constitutional BMFS from immune aplastic anemia in children is difficult due to subtle symptoms.
• Accurate diagnosis impacts prognosis, treatment, and transplant decisions.

Purpose of the Study:

• To present a structured diagnostic framework for pediatric bone marrow failure syndromes.
• To guide clinicians in differentiating constitutional BMFS from other causes of bone marrow failure.
• To improve diagnostic precision and patient outcomes.

Main Methods:

• Integration of clinical history, physical examination, and bone marrow morphology.
• Utilizing flow cytometry, cytogenetic analysis, and functional assays.
• Employing next-generation sequencing (NGS) for germline variant detection and chromosomal breakage testing for Fanconi anemia.
• Telomere length measurement to differentiate constitutional from immune BMF.

Main Results:

• NGS aids in variant detection and resolves ambiguous cases.
• Telomere length measurement is key for distinguishing constitutional BMF.
• Disease-specific patterns of clonal hematopoiesis refine diagnosis and risk stratification.
• Chromosomal breakage testing is the gold standard for Fanconi anemia.

Conclusions:

• A stepwise, evidence-based approach is crucial for early diagnosis of pediatric BMFS.
• Comprehensive diagnostic strategies improve risk stratification and patient management.
• Accurate differentiation ensures appropriate therapeutic strategies and surveillance.